Back to Search Start Over

Activation function 1 of progesterone receptor is required for progesterone antagonism of oestrogen action in the uterus.

Authors :
Lee, Shi Hao
Lim, Chew Leng
Shen, Wei
Tan, Samuel Ming Xuan
Woo, Amanda Rui En
Yap, Yeannie H. Y.
Sian, Caitlyn Ang Su
Goh, Wilson Wen Bin
Yu, Wei-Ping
Li, Li
Lin, Valerie C. L.
Source :
BMC Biology; 10/5/2022, Vol. 20 Issue 1, p1-18, 18p
Publication Year :
2022

Abstract

Background: Progesterone receptor (PGR) is a master regulator of uterine function through antagonistic and synergistic interplays with oestrogen receptors. PGR action is primarily mediated by activation functions AF1 and AF2, but their physiological significance is unknown. Results: We report the first study of AF1 function in mice. The AF1 mutant mice are infertile with impaired implantation and decidualization. This is associated with a delay in the cessation of epithelial proliferation and in the initiation of stromal proliferation at preimplantation. Despite tissue selective effect on PGR target genes, AF1 mutations caused global loss of the antioestrogenic activity of progesterone in both pregnant and ovariectomized models. Importantly, the study provides evidence that PGR can exert an antioestrogenic effect by genomic inhibition of Esr1 and Greb1 expression. ChIP-Seq data mining reveals intermingled PGR and ESR1 binding on Esr1 and Greb1 gene enhancers. Chromatin conformation analysis shows reduced interactions in these genes' loci in the mutant, coinciding with their upregulations. Conclusion: AF1 mediates genomic inhibition of ESR1 action globally whilst it also has tissue-selective effect on PGR target genes. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
17417007
Volume :
20
Issue :
1
Database :
Complementary Index
Journal :
BMC Biology
Publication Type :
Academic Journal
Accession number :
159499161
Full Text :
https://doi.org/10.1186/s12915-022-01410-3